Evaluation of the Final Adult Height and Its Determinants in Patients with Growth Hormone Deficiency: A Single-centre Experience from the South-eastern Region of Turkey
Conclusion: GH treatment provided the majority of our patients to achieve a final height compatible with their genetic potential as well as population standards. First Year Delta Height-SDS was found a predictive factor for FAH. Commencement of GH therapy at the prepubertal period was not found associated with a better height outcome.
PMID: 32157854 [PubMed - as supplied by publisher]
Source: JCRPE Journal of Clinical Research in Pediatric Endocrinology - Category: Endocrinology Tags: J Clin Res Pediatr Endocrinol Source Type: research
More News: Endocrinology | Genetics | Hormones | Middle East Health | Pediatrics | Study | Turkey Health